European Opportunities Trust plc (EOT) ORD GBP0.01
Sell:800.00p
Buy:802.00p
0
Change:
1.00p
(0.12%)
FTSE 250:0.16%
Market closed |
Prices as at close on 19 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- Create an alert
- This stock can be held in a
Sell:800.00p
Buy:802.00p
Change:
1.00p
(0.12%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 19 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Ex-dividend
Sell:800.00p
Buy:802.00p
Change:
1.00p
(0.12%)
Market closed |
Prices as at close on 19 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Ex-dividend
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
HL comment
Objective
The objective of the company is to invest in securities of European companies and in sectors or geographical areas which are considered by the investment manager to offer good prospects for capital growth, taking into account economic trends and business development.
Security | Weight |
---|---|
Novo Nordisk DKK0.1 B | 12.67% |
Experian Plc Ordinary USD0.10 | 8.84% |
RELX plc Ord 14 51/116p | 8.12% |
Deutsche Boerse AG NPV | 7.91% |
Dassault Systemes SE EUR0.10 | 7.29% |
Genus plc Ordinary 10p | 6.54% |
Intermediate Capital Group Ord GBP0.2625 | 5.85% |
Prysmian Spa Eur0.10 | 5.12% |
Edenred SE Eur2 | 4.84% |
Biomerieux EUR1 | 4.40% |
Sector | Weight |
---|---|
Healthcare | 34.07% |
Industrials | 28.84% |
Financial Services | 19.84% |
Technology | 16.83% |
Energy | 4.14% |
Communication Services | 3.34% |
Basic Materials | 2.39% |
Country | Weight |
---|---|
United Kingdom | 33.81% |
France | 24.97% |
Denmark | 14.41% |
Germany | 14.02% |
Italy | 6.35% |
Sweden | 4.79% |
Spain | 4.54% |
Ireland | 3.31% |
Netherlands | 2.23% |
Switzerland | 1.01% |
Fee Structure
The management company will be paid aggregate management fees of 0.80% per annum of net assets up to 1 billion 0.70% per annum on any net assets over 1 billion up to 1.25 billion and 0.60% per annum on any net assets over this amount.
Dividend Policy
The Company’s objective is to achieve shareholder returns through capital growth rather than income. However, in order to qualify for approval as an investment trust, the Company is not permitted to retain more than 15% of eligible investment income arising during any accounting period. Accordingly, the Board’s policy is to propose a modest annual dividend and one at least sufficient to enable the Company to maintain its investment trust status.
ASSET SPLIT
Trust Manager
Not currently available for this investment trust.
Manager Bio
Not currently available for this investment trust.
Board Of Directors
Matthew DobbsChairman, Sharon Brown, Neeta Patel, Jeroen Huysinga, Manisha Shukla
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.